PRPO

Precipio (PRPO)

About Precipio (PRPO)

Precipio, Inc.is a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. Its products include ICP, HemeScreen, and IV-Cell, and services include primary diagnostic, SmartPath, SmartGen, HemeScreen Panel, and ICE COLD-PCR. The company was founded on March 6, 1997 and is headquartered in New Haven, CT.

Details

Daily high

$6.64

Daily low

$6.01

Price at open

$6.61

52 Week High

$8.99

52 Week Low

$4.31

Market cap

9.5M

Dividend yield

0.00%

Volume

12,583

Avg. volume

8,836

P/E ratio

-2.39

Precipio News